Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Yesim Ozguler, Sinem Nihal Esatoglu & Gulen Hatemi. (2023) Current pharmacological solutions for Behçet’s syndrome. Expert Opinion on Pharmacotherapy 24:2, pages 221-231.
Read now
Read now
Daniel Pak & Hyon Ju Park. (2023) Behcet disease: an undifferentiating and complex vasculitis. Postgraduate Medicine 135:sup1, pages 33-43.
Read now
Read now
Yesim Ozguler, Ayse Ozdede & Gulen Hatemi. (2021) Recent Insights into the Management of Behçet Syndrome. Journal of Inflammation Research 14, pages 3429-3441.
Read now
Read now
Burçin Cansu Bozca & Erkan Alpsoy. (2021) Experimental Therapeutic Solutions for Behcet’s Disease. Journal of Experimental Pharmacology 13, pages 127-145.
Read now
Read now
Tara Nazareth, Erin M Hart, Sarah M Ronnebaum, Sandhya Mehta, Dipen A Patel & Ina Kötter. (2020) Comparability of European League Against Rheumatology-Recommended Pharmacological Treatments of Oral Ulcers Associated with Behçet’s Disease: A Systematic Literature Review of Randomized Controlled Trials. Open Access Rheumatology: Research and Reviews 12, pages 323-335.
Read now
Read now
Giuseppe Lopalco, Donato Rigante, Antonio Lopalco, Giacomo Emmi, Vincenzo Venerito, Antonio Vitale, Giovanna Capozio, Nunzio Denora, Luca Cantarini & Florenzo Iannone. (2020) Safety of systemic treatments for Behçet’s syndrome. Expert Opinion on Drug Safety 19:10, pages 1269-1301.
Read now
Read now
Gulen Hatemi & Yusuf Yazici. (2017) Apremilast for the treatment of Behcet’s syndrome. Expert Opinion on Orphan Drugs 5:8, pages 677-681.
Read now
Read now
Ryo Rokutanda, Mitsumasa Kishimoto & Masato Okada. (2015) Update on the diagnosis and management of Behçet’s disease. Open Access Rheumatology: Research and Reviews 7, pages 1-8.
Read now
Read now
Ina Kötter. (2015) The challenging treatment of Behcet’s disease. Expert Opinion on Orphan Drugs 3:10, pages 1101-1110.
Read now
Read now
Shunsei Hirohata, Hirotoshi Kikuchi, Tetsuji Sawada, Hiroko Nagafuchi, Masataka Kuwana, Mitsuhiro Takeno & Yoshiaki Ishigatsubo. (2014) Analysis of various factors on the relapse of acute neurological attacks in Behçet's disease. Modern Rheumatology 24:6, pages 961-965.
Read now
Read now
Articles from other publishers (74)
Alvaro Cavalheiro Soares, Fabio Ramoa Pires, Nara Regina de Oliveira Quintanilha, Lilian Rocha Santos, Thaylla Nunez Amin Dick, Arkadiusz Dziedzic & Bruna Lavinas Sayed Picciani. (2023) Oral Lesions as the Primary Manifestations of Behçet’s Disease: The Importance of Interdisciplinary Diagnostics—A Case Report. Biomedicines 11:7, pages 1882.
Crossref
Crossref
Jennifer S. Hanberg & Eli M. Miloslavsky. (2023) Steroid sparing in vasculitis: Myth or reality?. Best Practice & Research Clinical Rheumatology, pages 101843.
Crossref
Crossref
Teresa Giani, Angela Flavia Luppino & Giovanna Ferrara. (2023) Treatment Options in Pediatric Behçet’s Disease. Pediatric Drugs 25:2, pages 165-191.
Crossref
Crossref
Zeyuan Wang, Xiaoman Zu, Shanshan Xiong, Ren Mao, Yun Qiu, Baili Chen, Zhirong Zeng, Minhu Chen & Yao He. (2023) The Role of Colchicine in Different Clinical Phenotypes of Behcet Disease. Clinical Therapeutics 45:2, pages 162-176.
Crossref
Crossref
George E. Fragoulis, George Bertsias, Bahram Bodaghi, Ahmet Gul, Jan van Laar, Gonca Mumcu, David Saadoun, Ilknur Tugal-Tutkun, Gulen Hatemi & Petros P. Sfikakis. (2023) Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?. Clinical Immunology 246, pages 109186.
Crossref
Crossref
Johannes Nowatzky, Gulen Hatemi, Vedat Hamuryudan, Hasan Yazici & Yusuf Yazici. 2023. A Clinician's Pearls & Myths in Rheumatology. A Clinician's Pearls & Myths in Rheumatology
311
325
.
Emily Burns, Elizabeth Cooper, Rosemary Peterson & Lucia Z. Diaz. (2022) Pediatric Behҫet disease: Update in diagnosis and management. Pediatric Dermatology 39:2, pages 173-181.
Crossref
Crossref
Sara Trevisini, Giusto Trevisan, Iris Zalaudek & Serena Bonin. (2022)
Adamantiades‐Behçet
's disease therapy: current treatment options and recommendations with regard to the
COVID
‐19 pandemic
. Dermatologic Therapy 35:3.
Crossref
Crossref
T.B. van der Houwen, P.M. van Hagen & J.A.M. van Laar. (2022) Immunopathogenesis of Behçet's disease and treatment modalities. Seminars in Arthritis and Rheumatism 52, pages 151956.
Crossref
Crossref
Ami Schattner. (2022) Colchicine – new horizons for an ancient drug. Review based on the highest hierarchy of evidence. European Journal of Internal Medicine 96, pages 34-41.
Crossref
Crossref
Stefano Dastoli, Steven Paul Nisticò, Pietro Morrone, Cataldo Patruno, Antonio Leo, Rita Citraro, Luca Gallelli, Emilio Russo, Giovambattista De Sarro & Luigi Bennardo. (2022) Colchicine in Managing Skin Conditions: A Systematic Review. Pharmaceutics 14:2, pages 294.
Crossref
Crossref
Petros Efthimiou, Olga Petryna, Priscila Nakasato & Apostolos Kontzias. (2022) New insights on multigenic autoinflammatory diseases. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2211178.
Crossref
Crossref
Daniel R. Mazori & Alisa N. Femia. 2022. Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology. Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology
225
270
.
Worawit Louthrenoo. (2021) Behcet’s Disease in Southeast Asia. Clinical Features, Genetic Study, and Review of Recent Treatment. Journal of Clinical Rheumatology and Immunology 21:01, pages 22-36.
Crossref
Crossref
Aliye Gediz Erturk, Arzu Sahin, Ebru Bati Ay, Emel Pelit, Emine Bagdatli, Irem Kulu, Melek Gul, Seda Mesci, Serpil Eryilmaz, Sirin Oba Ilter & Tuba Yildirim. (2021) A Multidisciplinary Approach to Coronavirus Disease (COVID-19). Molecules 26:12, pages 3526.
Crossref
Crossref
Javier Rodríguez-Carrio, Valeria Nucera, Ignazio Francesco Masala & Fabiola Atzeni. (2021) Behçet disease: From pathogenesis to novel therapeutic options. Pharmacological Research 167, pages 105593.
Crossref
Crossref
Erkan Alpsoy, Pietro Leccese, Giacomo Emmi & Shigeaki Ohno. (2021) Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach. Frontiers in Medicine 8.
Crossref
Crossref
Sei Muraoka, Miwa Kanaji, Keiko Koshiba & Toshihiro Nanki. (2021) Successful treatment of refractory mucocutaneous involvement in a Behçet disease patient with apremilast. Medicine: Case Reports and Study Protocols 2:2, pages e0050.
Crossref
Crossref
Timothy McEwan & Philip C Robinson. (2021) A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections. Seminars in Arthritis and Rheumatism 51:1, pages 101-112.
Crossref
Crossref
Haralampos M. Moutsopoulos & Evangelia Zampeli. 2021. Immunology and Rheumatology in Questions. Immunology and Rheumatology in Questions
205
243
.
Sarah Stewart, Kevin Chih Kai Yang, Kate Atkins, Nicola Dalbeth & Philip C. Robinson. (2020) Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthritis Research & Therapy 22:1.
Crossref
Crossref
Marco Cabras, Marco Carrozzo, Alessio Gambino, Roberto Broccoletti, Savino Sciascia, Simone Baldovino & Paolo Giacomo Arduino. (2020) Value of colchicine as treatment for recurrent oral ulcers: A systematic review. Journal of Oral Pathology & Medicine 49:8, pages 731-740.
Crossref
Crossref
Omer Karadag & Ertugrul Cagri Bolek. (2020) Management of Behcet’s syndrome. Rheumatology 59:Supplement_3, pages iii108-iii117.
Crossref
Crossref
Clare E. Pain. (2020) Juvenile-onset Behçet's syndrome and mimics. Clinical Immunology 214, pages 108381.
Crossref
Crossref
Daishi Nonaka, Hiroyuki Takase, Masashi Machii & Kazuto Ohno. (2020) Colchicine therapy for deep vein thrombosis in a patient with vascular-type Behçet disease. Medicine 99:16, pages e19814.
Crossref
Crossref
Koichiro Nakamura, Yohei Iwata, Jun Asai, Tamihiro Kawakami, Yuichiro Tsunemi, Masaki Takeuchi, Nobuhisa Mizuki & Fumio Kaneko. (2020) Guidelines for the treatment of skin and mucosal lesions in Behçet's disease: A secondary publication. The Journal of Dermatology 47:3, pages 223-235.
Crossref
Crossref
Giacomo De Luca, Adriana Cariddi, Corrado Campochiaro, Daniele Vanni, Nicola Boffini, Alessandro Tomelleri, Giulio Cavalli & Lorenzo Dagna. (2020) Efficacy and safety of apremilast for Behçet’s syndrome: a real-life single-centre Italian experience. Rheumatology 59:1, pages 171-175.
Crossref
Crossref
Yusuf Yazici, Emire Seyahi, Gulen Hatemi & Hasan Yazici. 2020. Behçet Syndrome. Behçet Syndrome
315
319
.
Sibel Ersoy‐Evans, Ayşen Karaduman & Seza Özen. 2019. Harper's Textbook of Pediatric Dermatology. Harper's Textbook of Pediatric Dermatology
1952
1960
.
Sinem Nihal Esatoglu & Gulen Hatemi. (2019) Update on the treatment of Behçet’s syndrome. Internal and Emergency Medicine 14:5, pages 661-675.
Crossref
Crossref
Necmettin Akdeniz, Ömer Faruk Elmas & Ayşe Serap Karadağ. (2019) Behçet syndrome: A great imitator. Clinics in Dermatology 37:3, pages 227-239.
Crossref
Crossref
Pietro Leccese, Yesim Ozguler, Robin Christensen, Sinem Nihal Esatoglu, Dongsik Bang, Bahram Bodaghi, Aykut Ferhat Celik, Farida Fortune, Julien Gaudric, Ahmet Gül, Ina Kötter, Alfred Mahr, Robert J. Moots, Jutta Richter, David Saadoun, Carlo Salvarani, Francesco Scuderi, Petros P. Sfikakis, Aksel Siva, Miles Stanford, Ilknur Tugal-Tutkun, Richard West, Sebahattin Yurdakul, Ignazio Olivieri, Hasan Yazici & Gulen Hatemi. (2019) Management of skin, mucosa and joint involvement of Behçet’s syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome. Seminars in Arthritis and Rheumatism 48:4, pages 752-762.
Crossref
Crossref
Caroline A. Nelson, Sasha Stephen, Hovik J. Ashchyan, William D. James, Robert G. Micheletti & Misha Rosenbach. (2018) Neutrophilic dermatoses. Journal of the American Academy of Dermatology 79:6, pages 987-1006.
Crossref
Crossref
Antonio Greco, Armando De Virgilio, Massimo Ralli, Andrea Ciofalo, Patrizia Mancini, Giuseppe Attanasio, Marco de Vincentiis & Alessandro Lambiase. (2018) Behçet's disease: New insights into pathophysiology, clinical features and treatment options. Autoimmunity Reviews 17:6, pages 567-575.
Crossref
Crossref
Andrea D. Maderal, Paul Lee SalisburyIIIIII & Joseph L. Jorizzo. (2018) Desquamative gingivitis. Journal of the American Academy of Dermatology 78:5, pages 851-861.
Crossref
Crossref
Gulen Hatemi, Robin Christensen, Dongsik Bang, Bahram Bodaghi, Aykut Ferhat Celik, Farida Fortune, Julien Gaudric, Ahmet Gul, Ina Kötter, Pietro Leccese, Alfred Mahr, Robert Moots, Yesim Ozguler, Jutta Richter, David Saadoun, Carlo Salvarani, Francesco Scuderi, Petros P Sfikakis, Aksel Siva, Miles Stanford, Ilknur Tugal-Tutkun, Richard West, Sebahattin Yurdakul, Ignazio Olivieri & Hasan Yazici. (2018) 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Annals of the Rheumatic Diseases, pages annrheumdis-2018-213225.
Crossref
Crossref
B. Dasgeb, D. KornreichK. McGuinnL. OkonI. BrownellD.L. Sackett. (2018) Colchicine: an ancient drug with novel applications. British Journal of Dermatology 178:2, pages 350-356.
Crossref
Crossref
Loic Guillevin, Chetan Mukhtyar, Christian Pagnoux & Max Yates. (2018) Conventional and biological immunosuppressants in vasculitis. Best Practice & Research Clinical Rheumatology 32:1, pages 94-111.
Crossref
Crossref
Hazel Squires, Edith Poku, Inigo Bermejo, Katy Cooper, John Stevens, Jean Hamilton, Ruth Wong, Alastair Denniston, Ian Pearce & Fahd Quhill. (2017) A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults. Health Technology Assessment 21:68, pages 1-170.
Crossref
Crossref
Adriana Cavazos‐Garduño, Julio C. Serrano‐Niño, Rebeca García‐Varela & Hugo S. García. 2017. Fruit and Vegetable Phytochemicals. Fruit and Vegetable Phytochemicals
53
66
.
Isil Bulur & Meltem Onder. (2017) Behçet disease: New aspects. Clinics in Dermatology 35:5, pages 421-434.
Crossref
Crossref
Maria Antonieta Rios Scherrer, Vanessa Barreto Rocha & Lucas Campos Garcia. (2017) Behçet's disease: review with emphasis on dermatological aspects. Anais Brasileiros de Dermatologia 92:4, pages 452-464.
Crossref
Crossref
Oh Chan Kwon, Seokchan Hong, Byeongzu Ghang, Yong-Gil Kim, Chang-Keun Lee & Bin Yoo. (2017) Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin. The American Journal of Medicine 130:5, pages 583-587.
Crossref
Crossref
Beltinge Demircioğlu Kılıc, Mehtap Akbalık Kara, Ayse Aysima Ozcelik, Hasim Ustunsoy & Ayse Balat. (2017) Brachial artery pseudoaneurysm: Rare finding in childhood Behcet's disease. Pediatrics International 59:1, pages 109-110.
Crossref
Crossref
William S. Kaufman, Elizabeth K. McNamara & Joseph L. Jorizzo. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology
1589
1596
.
Katherine L. Johnson & Marla N. Jahnke. 2017. Therapy in Pediatric Dermatology. Therapy in Pediatric Dermatology
421
443
.
Christos C. Zouboulis. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
12
.
Tamer A Gheita, Heba A Gheita & Sanaa A Kenawy. (2016) The potential of genetically guided treatment in Behçet's disease. Pharmacogenomics 17:10, pages 1165-1174.
Crossref
Crossref
Erkan Alpsoy. (2016) Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. The Journal of Dermatology 43:6, pages 620-632.
Crossref
Crossref
L. Vaillant, M. Samimi & D. Parent. (2016) Aftas, aftosis, enfermedad de Beh?et. EMC - Dermatolog?a 50:2, pages 1-14.
Crossref
Crossref
Karolyn A. Wanat, Benjamin Kim & Misha Rosenbach. (2016) Multisystem diseases affecting the skin and eye. Clinics in Dermatology 34:2, pages 214-241.
Crossref
Crossref
Lars G Hemkens, Hannah Ewald, Viktoria L Gloy, Armon Arpagaus, Kelechi K Olu, Mark Nidorf, Dominik Glinz, Alain J Nordmann & Matthias Briel. (2016) Colchicine for prevention of cardiovascular events. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ying Ying Leung, Laura Li Yao Hui & Virginia B. Kraus. (2015) Colchicine—Update on mechanisms of action and therapeutic uses. Seminars in Arthritis and Rheumatism 45:3, pages 341-350.
Crossref
Crossref
Jagdish R. Nair & Robert J. Moots. (2015) Beh?et's disease: Review of management. Indian Journal of Rheumatology 10, pages S84-S94.
Crossref
Crossref
Anastasia Slobodnick, Binita Shah, Michael H. Pillinger & Svetlana Krasnokutsky. (2015) Colchicine: Old and New. The American Journal of Medicine 128:5, pages 461-470.
Crossref
Crossref
Gulen Hatemi, Melike Melikoglu, Recep Tunc, Cengiz Korkmaz, Banu Turgut Ozturk, Cem Mat, Peter A. Merkel, Kenneth T. Calamia, Ziqi Liu, Lilia Pineda, Randall M. Stevens, Hasan Yazici & Yusuf Yazici. (2015) Apremilast for Beh?et?s Syndrome ? A Phase 2, Placebo-Controlled Study. New England Journal of Medicine 372:16, pages 1510-1518.
Crossref
Crossref
Sebastian H. Unizony, Nancy D. Kim & Mai P. Hoang. (2015) Case 7-2015. New England Journal of Medicine 372:9, pages 864-872.
Crossref
Crossref
Ora Singer. (2015) Cogan and Behcet Syndromes. Rheumatic Disease Clinics of North America 41:1, pages 75-91.
Crossref
Crossref
Christos C. Zouboulis. 2015. European Handbook of Dermatological Treatments. European Handbook of Dermatological Treatments
33
44
.
Eva Remenyik. 2015. European Handbook of Dermatological Treatments. European Handbook of Dermatological Treatments
277
283
.
Robert J Barry, Bharat Markandey, Rahul Malhotra, Henry Knott, Nikita Joji, Mohammed Mubin, Alastair K Denniston & Phillip I Murray. (2014) Evidence-based practice in Behçet’s disease: identifying areas of unmet need for 2014. Orphanet Journal of Rare Diseases 9:1.
Crossref
Crossref
Andreas Altenburg, Nadine El-Haj, Christiana Micheli, Marion Puttkammer, MohamBadawy Abdel-Naser & Christos C. Zouboulis. (2014) The Treatment of Chronic Recurrent Oral Aphthous Ulcers. Deutsches Ärzteblatt international.
Crossref
Crossref
Zeinab Saleh & Thurayya Arayssi. (2014) Update on the therapy of Behçet disease. Therapeutic Advances in Chronic Disease 5:3, pages 112-134.
Crossref
Crossref
Taraneh Dormohammadi Toosi, Farhad Shahram, S. Zahra Ghodsi, Abdolhadi Nadji, Arash Tehrani Banihashemi, Seyyedeh Roghieh Larimi & Fereydoun Davatchi. (2014) Iron deficiency state in resistant oral aphthosis of Behcet's disease. International Journal of Rheumatic Diseases 17:4, pages 425-429.
Crossref
Crossref
Yesim Ozguler, Gulen Hatemi & Hasan Yazici. (2014) Management of Behçet's syndrome. Current Opinion in Rheumatology 26:3, pages 285-291.
Crossref
Crossref
Jennifer Taylor, Paul Brocklehurst, Tanya Walsh, Philip Riley, Anne-Marie Glenny, Rachel Gorodkin & Michael N Pemberton. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Virendra N. Sehgal, Deepika Pandhi & Ananta Khurana. (2014) Nonspecific genital ulcers. Clinics in Dermatology 32:2, pages 259-274.
Crossref
Crossref
Carmelo Morales-Angulo, Sandra Vergara Pastrana, Sergio Obeso-Agüera, Leticia Acle & Miguel Ángel González-Gay. (2014) Manifestaciones otorrinolaringológicas en pacientes con enfermedad de Behçet. Acta Otorrinolaringológica Española 65:1, pages 15-21.
Crossref
Crossref
Carmelo Morales-Angulo, Sandra Vergara Pastrana, Sergio Obeso-Agüera, Leticia Acle & Miguel Ángel González-Gay. (2014) Otorhinolaryngological Manifestations in Patients With Behçet Disease. Acta Otorrinolaringologica (English Edition) 65:1, pages 15-21.
Crossref
Crossref
Adey Hasan, Hiren Patel, Hana Saleh, George Youngberg, John Litchfield & Guha Krishnaswamy. (2013) Remission of severe aphthous stomatitis of celiac disease with etanercept. Clinical and Molecular Allergy 11:1.
Crossref
Crossref
Crispian Scully. 2013. Oral and Maxillofacial Medicine. Oral and Maxillofacial Medicine
239
243
.
Paul Brocklehurst, Martin Tickle, Anne-Marie Glenny, Michael A Lewis, Michael N Pemberton, Jennifer Taylor, Tanya Walsh, Philip Riley & Julian M Yates. (2012) Systemic interventions for recurrent aphthous stomatitis (mouth ulcers). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Carla Maldini, Michael P. LaValley, Morgane Cheminant, Mathilde de Menthon & Alfred Mahr. (2012) Relationships of HLA-B51 or B5 genotype with Beh?et's disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology 51:5, pages 887-900.
Crossref
Crossref
Seza Özen. (2010) Pediatric onset Behçet disease. Current Opinion in Rheumatology 22:5, pages 585-589.
Crossref
Crossref